{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-083356","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2026-07-14T12:12:23+00:00","discovered_at":"2026-07-14T12:15:00.647924+00:00","generated_at":"2026-07-14T12:15:07.209875+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Yarrow Bioscience publishes investor presentation; VYNE makes available on website","bullets":["Yarrow Bioscience published an investor presentation dated July 14, 2026, which VYNE made available on its website.","The presentation is related to the proposed transaction between VYNE and Yarrow, as referenced in the S-4 registration statement.","No specific financial or operational details from the presentation are included in the filing text provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-083356","json":"https://secwatch.observer/filing/0001104659-26-083356.json","markdown":"https://secwatch.observer/filing/0001104659-26-083356.md","text":"https://secwatch.observer/filing/0001104659-26-083356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/0001104659-26-083356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/tm2620382d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T12:15:07.209875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}